This happened for the first time in history, every patient got rid of cancer in the drug trial

According to a New York Times report, a trial claimed that 18 rectal cancer patients were given the same drug for six months and as a result of the treatment, the cancer was completely eradicated in each patient.

cancer remains a major threat to the world even today. Medical science is doing new miracles every day. Meanwhile, a drug trial has been done, which has gotten rid of cancer in every patient. 18 patients involved in the initial trial of a drug for the treatment of rectal cancer have gotten rid of the disease.

According to the New York Times report, in a very small clinical trial, 18 patients took a drug called dostarlimab for about six months and in the end, each of them saw their tumor disappear.

Dosterlimumab is a drug containing molecules manufactured by the laboratory, which acts as a substitute antibody (substitute antibody) in the human body. All 18 rectal cancer patients were given the same drug and as a result of treatment, the cancer was completely eradicated in all patients. Physical tests such as endoscopy, positron emission tomography or PET scans, or MRI scans also did not show cancer.

Dr. Luis A. Diaz J, of York's Memorial Sloan Kettering cancer Center, said it was "the first time in the history of cancer". Dr. Diaz is one of the study authors.

 Notably, all patients were in similar stages of their cancer.

According to the New York Times, patients in clinical trials so far have had to undergo chemotherapy, radiation, and invasive surgery… in previous treatments to eradicate their cancer, which can result in bowel, urinary, and even sexual dysfunction. 18 patients went for the test hoping to undergo these in the next stage. However, no further treatment was needed for him.

cancer patients usually undergo difficult treatments, including surgery, chemotherapy, and radiation.

 Patients sometimes develop permanent problems like bowel, urinary defects, and even sexual dysfunction.

The result of this test has created panic in the medical world. Speaking to the media, Dr. Alan P. Venuk, who works as a colorectal cancer specialist at the university of California, said that the complete eradication of cancer in all patients is 'unbelievable'. He described this research as the first research in the world, where all the patients were cured.

The special thing is that no side effects have been shown for this medicine.

Dr. Andrea Cersek, an oncologist at Memorial Sloan Kettering cancer Center and co-author of the research paper, spoke of the moment patients learned they were cancer-free. He told the New York Times that "they all had tears of joy in their eyes." Now, cancer researchers reviewing the drug tell the media that the treatment looks promising, but a large-scale trial is needed to see if it will work for more patients and whether the cancer is really gone.

Dosterlimumab is a monoclonal drug, which acts as an antibody in the human body. The monoclonal antibody works together with a special protein called PD-1 on the surdata-face of cancer cells. It is effective in helping the immune system identify and destroy cancer cells.

During the trial, patients were given doses of it every three weeks for six months. None of the patients included in the trial had undergone chemoradiotherapy or surgery. During this, cancer did not spread from the rectum to other parts of the body, nor did the health of any patient deteriorate.

The cost of a 500mg dose of dosterlimumab in the US is approximately 8 lakh rupees ($11,000). Whereas, in the UK it is available for £5,887 per dose.